Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open-Label Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

NCT00552461 is registered in ClinicalTrials.gov with East Carolina University as lead sponsor.

NCT NCT00552461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00552461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open-Label Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
Lead sponsor
East Carolina University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2011
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary disease, pulmonary alveolar proteinosis